T. Rowe Price Investment Management’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,364
Closed -$147K 578
2023
Q2
$147K Sell
21,364
-1,695,701
-99% -$11.7M ﹤0.01% 564
2023
Q1
$13.4M Sell
1,717,065
-217,474
-11% -$1.69M 0.01% 500
2022
Q4
$14.7M Buy
1,934,539
+9,761
+0.5% +$74.3K 0.01% 487
2022
Q3
$15.7M Buy
+1,924,778
New +$15.7M 0.01% 473